12/17
01:07 pm
onc
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/17
01:07 pm
onc
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/18
10:27 am
onc
Rating for ONC
Low
Report
Rating for ONC
11/18
10:27 am
onc
Rating for ONC
Low
Report
Rating for ONC
11/10
04:29 pm
onc
Rating for ONC
Medium
Report
Rating for ONC
11/10
04:29 pm
onc
Rating for ONC
Medium
Report
Rating for ONC
11/7
01:16 pm
onc
Rating for ONC
Low
Report
Rating for ONC
11/7
01:16 pm
onc
Rating for ONC
Low
Report
Rating for ONC
10/20
11:24 am
onc
Rating for ONC
Low
Report
Rating for ONC
10/20
11:24 am
onc
Rating for ONC
Low
Report
Rating for ONC
10/20
11:15 am
onc
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
10/20
11:15 am
onc
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
10/8
01:29 pm
onc
Rating for ONC
Low
Report
Rating for ONC